ArticleChemistry & biodiversity2026
Qianjinweijingtang Decoction and Its Granule Inhibit Respiratory Syncytial Virus Infection and the Associated Inflammatory Response.
Article in Chemistry & biodiversity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
Respiratory syncytial virus infection (RSV) represents a leading cause behind acute lower respiratory infections affecting both children and older adults. Qianjinweijingtang (QJWJT), a classical Chinese herbal formula widely used for respiratory diseases, was investigated in this study to compare the anti-RSV efficacy and chemical profiles of its traditional decoction and granule formulation, and to elucidate the underlying mechanisms. Both formulations significantly inhibited RSV infection and its induced inflammatory responses in vitro and in vivo. Further mechanistic analysis revealed that QJWJT acted at an early step of the RSV replication cycle, most likely by interfering with viral entry. UHPLC-Q-Orbitrap HRMS analysis revealed that QJWJT was mainly composed of fatty acids, flavonoids, and phenolic acids, with isoliquiritigenin, quercetin, and gallic acid identified as key bioactive constituents. Moreover, all three compounds bound favorably to both the respiratory syncytial virus fusion (RSV-F) and glycoprotein (RSV-G). Network pharmacology combined with western blotting analysis indicated that QJWJT could inhibit RSV infection by downregulating Hypoxia-Inducible Factor 1-alpha (HIF-1α) expression. In conclusion, this study suggests that the granule formulation has the potential to serve as another option for the traditional decoction, providing a reference for the modernization of Chinese herbal formulas.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.